Overview
- 9 public-safe observations are available for this inspection.
- 3 structured CFR citations are represented.
- 3 investigators are tied to this Form 483.
Inspectional observations
Each observation cites the regulation FDA found the firm out of compliance with.
4 Apr 2016
21 CFR 211.188(b)(11)
Identification of Persons Performing Significant Steps
Cited by Michele L Obert, Brett R Havranek, Jeannie M Vonderbrink
4 Apr 2016
21 CFR 211.188(b)(11)
Identification of Persons Performing Significant Steps
Cited by Michele L Obert, Brett R Havranek, Jeannie M Vonderbrink
4 Apr 2016
21 CFR 211.188(b)(11)
Identification of Persons Performing Significant Steps
Cited by Michele L Obert, Brett R Havranek, Jeannie M Vonderbrink
4 Apr 2016
21 CFR 211.192
Investigations of discrepancies, failures
Cited by Michele L Obert, Brett R Havranek, Jeannie M Vonderbrink
4 Apr 2016
21 CFR 211.192
Investigations of discrepancies, failures
Cited by Michele L Obert, Brett R Havranek, Jeannie M Vonderbrink
Inspected site
MPMPP PHARMA LLCKansas City, United States
Inspection team
Cited regulations
CFR citations associated with this Form 483.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.188(b)(11) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.67(a) | Cited across public-safe Form 483 observations | 3x |
Full 483 report
Get the verbatim text of all 9 observations
Every observation in full, so your team sees exactly what was cited and how it was answered.
- The site's full inspection history around this Form 483
- Whether these citations escalated to a warning letter
- The investigators involved and the citations they repeat elsewhere